BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:Driving Innovation in Discovery and Chemistry\, Validating Cli
 nical Proof-of Concept and Streamlining CMC of Conjugates with Novel Payl
 oads and FormatsTraditional ADCs have seen significant success in recent 
 years\, but still face many challenges\, from limited payload capacities 
 to significant toxicities.\n\nGiven these limitations\, drug developers a
 re venturing beyond the conventional boundaries of conjugate drug design\
 , by exploring novel payloads and targeting formats\, with companies incl
 uding VincerX Pharma\, Dyne Therapeutics\, and Orum Therapeutics currentl
 y awaiting clinical validation.\n\nJoin 150+ of your peers to share learn
 ings and collaborate on novel design concepts\, key translational and cli
 nical development challenges\, and address challenging CMC roadblocks for
  the next generation of conjugated therapeutics\, including antibody-olig
 onucleotide conjugates\, fragment-drug conjugates\, antibody-degrader con
 jugates\, small molecule-drug conjugates\, and bispecific-drug conjugates
  and more!\n
DTEND:20240228T170000
DTSTAMP:20260512T231937Z
DTSTART:20240226T083000
LOCATION:Hotel Commonwealth\, 500\, Commonwealth Avenue\, Boston\, Massach
 usetts\, 02215\,
SEQUENCE:0
SUMMARY:Driving Innovation in Discovery and Chemistry\, Validating Clinica
 l Proof-of Concept and Streamlining CMC of Conjugates with Novel Payloads
  and Form...
UID:ba365ffd-4fad-4bb9-9af3-0a383293c7a1
END:VEVENT
END:VCALENDAR